The aim is to study the potency, purity, safety, and stability of the lyophilized human diploid cell rabies vaccine (HDCV). The viruses were harvested from infected human diploid cells (MRC-5 strain) which were cultured in a microcarrier bioreactor. After harvest, purification, inactivation and lyophilization, HDCV was produced. The potency of vaccines was measured by NIH method; the bovine serum protein residual content and the antibiotic residues were tested by ELISA method; the endotoxin content was detected by semi quantitative gel method; the safety of vaccine was determined in vivo. Among 6 batches of HDCV, the lowest immunizing potency was 4.79 IU/ml, whilst the highest was 6.03 IU/ml; the lowest bovine serum protein residual content was 12.41 ng/dose, whilst the highest was 31.74 ng/Dose; the content of antibiotic residues was from 2.20 ng/ml to 4.00 ng/ml; endotoxin levels were all lower than 50 EU/dose. All the mice and guinea pigs vaccinated were all alive, and the body weight of each mouse also increased. The stability was investigated by determining the water content and potency of the vaccine placed in 37±1 °C for 4 weeks and 2-8 °C for 48 months, respectively. The results indicate all the quality index accords with the standards of "Pharmacopoeia of the People's Republic of China 2010, 3 Volumes". HDCV shows satisfactory potency, purity, safety, and stability.
Introduction
Rabies is an acute zoonotic infectious disease caused by the rabies virus affecting the central nervous system. It is usually transmitted by a bite from an infected mammal [1, 2] . Rabies is virtually a 100% fatal disease whose incubation period is long [3, 4] . Misdiagnosis is quite frequently in the early phase, especially in children and subjects bitten by unknown animals [5] .
Appropriate pre-or post-exposure rabies vaccination is the only effective method to control human rabies [6] . Yet most human rabies vaccines in the market have poor safety, as they are made from infinite cell lines which might have the risks of tumorigenicity [7] .
The potency, purity, safety, and stability of rabies vaccines are the key index of the quality. To investigate rabies antibody titer is a method of determining whether the rabies is preventable by rabies vaccines [8] . Thus, rabies antibody titer might be indicative of preventative and protective effects of rabies vaccines [9] . The ideal rabies vaccine can not only induce the cell immune responses, but also maintain enough long time of protection [10] . Pitman-Moore (PM) virus strain is suggested to produce human diploid cell vaccine [11] . And MRC-5 has been already proved to be cultivated on Cytodex I microcarriers in a bioreactor [12] . The pro--duction process of the lyophilized human Table 1 ). [14, 15] . Nevertheless, if the exogenous DNA residues of the vaccines can not be strictly controlled, it might cause tumorigenesis. Few researches are focused on the quality of human diploid cell rabies vaccines made from healthy human embryo lung cells which have no risks of tumorigenesis [16] .
Traditional ways for human diploid cell 
